Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK.
Nucleic Acids Res. 2010 Mar;38(4):1228-39. doi: 10.1093/nar/gkp1102. Epub 2009 Dec 3.
Dr1 (also known as NC2beta) was identified as a repressor of RNA polymerase (pol) II transcription. It was subsequently shown to inhibit pol III transcription when expressed at high levels in vitro or in yeast cells. However, endogenous Dr1 was not detected at pol III-transcribed genes in growing yeast. In contrast, we demonstrate that endogenous Dr1 is present at pol III templates in human cells, as is its dimerization partner DRAP1 (also called NC2alpha). Expression of tRNA by pol III is selectively enhanced by RNAi-mediated depletion of endogenous human Dr1, but we found no evidence that DRAP1 influences pol III output in vivo. A stable association was detected between endogenous Dr1 and the pol III-specific transcription factor Brf1. This interaction may recruit Dr1 to pol III templates in vivo, as crosslinking to these sites increases following Brf1 induction. On the basis of these data, we conclude that the physiological functions of human Dr1 include regulation of pol III transcription.
DR1(也称为 NC2beta)被鉴定为 RNA 聚合酶(pol)II 转录的抑制剂。随后的研究表明,当它在体外或酵母细胞中高水平表达时,会抑制 pol III 转录。然而,在生长中的酵母中,内源性 DR1 并未在 pol III 转录的基因上检测到。相比之下,我们证明内源性 DR1 存在于人类细胞中的 pol III 模板上,其二聚化伴侣 DRAP1(也称为 NC2alpha)也是如此。通过 RNAi 介导的内源性人 DR1 耗竭,选择性地增强了 pol III 表达的 tRNA,但我们没有发现 DRAP1 会影响体内 pol III 输出的证据。在体内检测到内源性 DR1 与 pol III 特异性转录因子 Brf1 之间存在稳定的相互作用。这种相互作用可能会将 DR1 招募到 pol III 模板上,因为 Brf1 诱导后与这些位点的交联增加。基于这些数据,我们得出结论,人 DR1 的生理功能包括调节 pol III 转录。